Member Login
  1. Stocks
    2. /
  2. Hikma Pharmaceuticals PLC (LSE: HIK)
    3. /

LSE:HIK (Hikma Pharmaceuticals PLC)

About HIK

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of Hikmas operations are in the United States, the Middle East and North Africa Region and Europe.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Hikma Pharmaceuticals PLC (LSE: HIK) Latest News

Investing Articles

Which of these Footsie healthcare stars should you buy after today’s news?

| Royston Wild

Royston Wild discusses the investment prospects of two Footsie medical giants.

Read more »

Investing Articles

Why did shares in Hikma Pharmaceuticals plc and GlaxoSmithKline plc crash last week?

| Rupert Hargreaves

Shares in GlaxoSmithKline plc (LON: GSK) and Hikma Pharmaceuticals plc (LON: HIK) are crashing but should you sell?

Read more »

Investing Articles

Should you ditch these Footsie pharma stocks right now!

| G A Chester

Are these blue chips now too dicey to hold?

Read more »

Investing Articles

2 firms to retire on

| Kevin Godbold

Here’s an elegant strategy for a financially worry-free retirement.

Read more »

Investing Articles

Top stocks for November

| The Motley Fool Staff

We asked our analysts to share their top stock picks for the coming month.

Read more »

Investing Articles

Directors are buying these high growth stocks – should you follow them?

| Edward Sheldon, CFA

Edward Sheldon looks at two stocks that have seen sizeable director's purchases in September.

Read more »

Investing Articles

Are these the FTSE 100’s best contrarian bets?

| Royston Wild

Royston Wild reveals two FTSE 100 (INDEXFTSE: UKX) giants well overdue for a share price upturn.

Read more »

Investing Articles

Should you buy GlaxoSmithKline plc after its change in CEO?

| Peter Stephens

Is GlaxoSmithKline plc (LON: GSK) more or less appealing after a change in senior management?

Read more »

Investing Articles

Is this the best healthcare stock money can buy after today’s update?

| Peter Stephens

Should you buy this stock or a sector peer following today's news?

Read more »

Investing Articles

These FTSE 100 giants sank in August! Can they bounce back?

| Royston Wild

Royston Wild looks at the share price prospects of three recent FTSE 100 (INDEXFTSE: UKX) fallers.

Read more »

Investing Articles

Is Hikma Pharmaceuticals plc the best FTSE 100 healthcare stock to own after today’s update?

| Edward Sheldon, CFA

Edward Sheldon looks at Hikma Pharmaceuticals plc's (LON: HIK) interim results statement and examines whether the long-term growth story is…

Read more »

Investing Articles

Is this stock the best buy in its sector following today’s update?

| Peter Stephens

Should you buy this stock over two industry peers?

Read more »